This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Universitè Laval. Active years: 2013-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Québec, CA (2013 - 2016)
- Quebec, CA (2017)
Company Filing History:
Years Active: 2013-2017
Title: Innovations by Michel J Tremblay: A Pioneer in HIV Research
Introduction
Michel J Tremblay is an innovative inventor based in Québec, Canada, renowned for his significant contributions to medical research, particularly in the field of HIV. With a total of three patents to his name, Tremblay's work focuses on groundbreaking therapeutic applications aimed at combating human immunodeficiency virus type-1 (HIV-1).
Latest Patents
Tremblay's latest patents showcase his dedication to advancing antiviral therapies. One of his prominent inventions involves three-dimensional cavities of dendritic cell immunoreceptor (DCIR), and the compounds binding to these structures. This patent details therapeutic methods for preventing or reducing HIV-1 infection, outlining the role of compounds that interact with DCIR, aiding in inhibiting virus binding and propagation within human cells. Another key patent focuses on compounds and pharmaceutical compositions detrimental to DCIR activity and signaling. This innovation provides critical insights into preventing or treating viral infections through intracellular modulators, specifically addressing HIV binding, entry, and replication.
Career Highlights
Throughout his career, Michel J Tremblay has collaborated with esteemed institutions such as Université Laval, where he furthered his research in HIV therapies. His expertise is duly recognized in the scientific community, contributing to the advancement of antiviral research aimed at alleviating the global impact of HIV.
Collaborations
Tremblay has worked alongside accomplished colleagues, including Caroline Gilbert and Alexandra Lambert. Their collaborative efforts have enhanced the research output and enriched the scientific discourse surrounding effective HIV treatments, evidencing Tremblay's commitment to teamwork and innovation in his field.
Conclusion
Michel J Tremblay's innovative contributions to the field of HIV research exemplify his role as a forward-thinking inventor. With three patents to his credit, his work not only highlights the potential for novel therapeutic applications but also emphasizes the importance of collaboration in advancing scientific knowledge. Tremblay continues to inspire the next generation of researchers in the pursuit of effective HIV treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile